Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

for
Lung Cancer, Gastrointestinal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06420206

Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Houston TX, Austin TX, Corpus Christi TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase2, Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for
Classic Follicular Lymphoma,
Location: Houston TX, San Antonio TX, Baton Rouge LA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase3, Recruiting

A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

for
T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma
Location: Houston TX
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04496349

Phase2, Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Houston TX, Dallas TX, Fort Worth TX, Jackson MS,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Sugar Land TX, Dallas TX, Baton Rouge LA, Daphne AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

for
Malignant Glioma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04771806

Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

for
Cardiac Failure, Graft Rejection
Location: Houston TX, Nashville TN, Aurora CO, Chicago IL,
Sponsor: Northwestern University

Sex: All

Age: 0 - 18

Code: NCT06532890

Recruiting

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

for
Propionic Acidemia
Location: Houston TX, Chicago IL, Durham NC, Ann Arbor MI,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 0+

Code: NCT04159103

Phase1, Phase2, Recruiting

Personalized NK Cell Therapy in CBT

for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 15 - 70+

Code: NCT02727803

Phase2, Recruiting

Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma

for
Cutaneous Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04778449

Recruiting

Proton or Photon RT for Retroperitoneal Sarcomas

for
Retroperitoneal Sarcoma
Location: Houston TX, St Louis MO, Creve Coeur MO, Chicago IL,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT01659203

Phase1, Phase2, Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

for
B-cell Acute Lymphoblastic Leukemia,
Location: Houston TX, Kansas City MO, St. Petersburg FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 25

Code: NCT06395103

Phase1, Phase2, Recruiting

Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children

for
Child, Intensive Care Unit Acquired Weakness, Critical Illness,
Location: Houston TX, Louisville KY, Orlando FL, Milwaukee WI,
Sponsor: Johns Hopkins University

Sex: All

Age: 0 - 18

Code: NCT04989790

Recruiting

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06566443

Phase1, Recruiting

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

for
Advanced Chronic Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06401603

Phase1, Recruiting

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

for
Hematologic Malignancies
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 60

Code: NCT06807606

Phase2, Recruiting

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

for
Gastrostomy, Gastric, GastroEsophageal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05205343

Recruiting

Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women

for
Obesity-Related Malignant Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18 - 65

Code: NCT05053113

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for
Myelodysplastic Syndromes, Cytopenia
Location: Houston TX, Hot Springs AR, Memphis TN, Tampa FL,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase2, Recruiting